Rheumatoid Arthritis Treatment Options and Type 2 Diabetes: Unravelling the Association Claudia Di MuzioPaola CiprianiPiero Ruscitti Leading Article Open access 02 November 2022 Pages: 673 - 685
Localised Delivery of Macromolecules to the Large Intestine: Translation to Clinical Trials David J. Brayden Leading Article 25 October 2022 Pages: 687 - 700
Extracellular Vesicles Derived from Mesenchymal Stem Cells: A Potential Biodrug for Acute Respiratory Distress Syndrome Treatment Hao SunTianyuan ZhangJianqing Gao Review Article 10 September 2022 Pages: 701 - 715
Non-small Cell Lung Cancer with EGFR or HER2 Exon 20 Insertion Mutations: Diagnosis and Treatment Options Danielle BrazelGianna KroeningMisako Nagasaka Review Article Open access 18 October 2022 Pages: 717 - 729
Assessing Immunogenicity of Biologic Drugs in Inflammatory Joint Diseases: Progress Towards Personalized Medicine Johanna Elin GehinGuro Løvik GollSilje Watterdal Syversen Review Article Open access 31 October 2022 Pages: 731 - 748
Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial Claire VerschraegenZoran AndricYuichiro Ohe Original Research Article Open access 28 September 2022 Pages: 749 - 760
Immunogenicity, Efficacy, and Safety of Biosimilar Insulin Aspart (MYL-1601D) Compared with Originator Insulin Aspart (Novolog®) in Patients with Type 1 Diabetes After 24 Weeks: A Randomized Open-Label Study Thomas C. BlevinsYaron RaiterAbhijit Barve Original Research Article Open access 17 September 2022 Pages: 761 - 772
The Economic Burden of CAR T Cell Therapies Ciltacabtagene Autoleucel and Idecabtagene Vicleucel for the Treatment of Adult Patients with Relapsed or Refractory Multiple Myeloma in the US Buthainah GhanemLu Shi Original Research Article 27 September 2022 Pages: 773 - 780
Lower Limbs are the Most Difficult-to-Treat Body Region of Patients with Psoriasis: Pooled Analysis of CLEAR and CLARITY Studies of Secukinumab Versus Ustekinumab by Body Region Miguel AlpalhãoJoana DuartePaulo Filipe Original Research Article 05 November 2022 Pages: 781 - 789
Correction: Immunotherapy in Gastro-Oesophageal Cancer: Current Practice and the Future of Personalised Therapy Mary E. BoothElizabeth C. Smyth Correction 15 October 2022 Pages: 791 - 791